Clinical Trials Browser

Completed × ADI PEG20 × 1 year × Clear all

NCT03922880 2025-05-15

Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

Phase 1 Completed

Uveal Melanoma